UnitedHealth Group Inc (UNH) Shares Bought by Corient Capital Partners LLC
Corient Capital Partners LLC boosted its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 57.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,652 shares of the healthcare conglomerate’s stock after buying an additional 2,803 shares during the period. Corient Capital Partners LLC’s holdings in UnitedHealth Group were worth $1,906,000 as of its most recent SEC filing.
A number of other large investors have also bought and sold shares of UNH. Brookstone Capital Management increased its holdings in UnitedHealth Group by 13.0% in the third quarter. Brookstone Capital Management now owns 3,838 shares of the healthcare conglomerate’s stock worth $1,021,000 after buying an additional 442 shares during the last quarter. FTB Advisors Inc. increased its holdings in UnitedHealth Group by 6.7% in the third quarter. FTB Advisors Inc. now owns 4,641 shares of the healthcare conglomerate’s stock worth $3,038,000 after buying an additional 292 shares during the last quarter. ProVise Management Group LLC acquired a new position in UnitedHealth Group in the third quarter worth approximately $580,000. Becker Capital Management Inc. increased its holdings in UnitedHealth Group by 7.5% in the third quarter. Becker Capital Management Inc. now owns 5,004 shares of the healthcare conglomerate’s stock worth $1,331,000 after buying an additional 350 shares during the last quarter. Finally, Main Street Research LLC increased its holdings in UnitedHealth Group by 2.9% in the third quarter. Main Street Research LLC now owns 88,367 shares of the healthcare conglomerate’s stock worth $23,509,000 after buying an additional 2,495 shares during the last quarter. 85.80% of the stock is owned by institutional investors.
In other news, Director Gail R. Wilensky sold 2,930 shares of the stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the completion of the sale, the director now directly owns 64,726 shares of the company’s stock, valued at $16,400,921.14. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction that occurred on Thursday, January 17th. The shares were sold at an average price of $260.55, for a total value of $3,908,250.00. Following the completion of the sale, the director now directly owns 193,872 shares of the company’s stock, valued at $50,513,349.60. The disclosure for this sale can be found here. Insiders sold 27,930 shares of company stock valued at $7,208,783 over the last three months. 0.87% of the stock is owned by company insiders.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, beating the consensus estimate of $3.20 by $0.08. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The company had revenue of $58.42 billion during the quarter, compared to analysts’ expectations of $58.01 billion. During the same period in the prior year, the business earned $2.59 earnings per share. UnitedHealth Group’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Inc will post 14.62 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th will be given a $0.90 dividend. The ex-dividend date of this dividend is Friday, March 8th. This represents a $3.60 annualized dividend and a dividend yield of 1.43%. UnitedHealth Group’s dividend payout ratio is 27.95%.
A number of equities analysts recently commented on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $305.00 price objective on the stock in a report on Friday, December 14th. BMO Capital Markets set a $310.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a report on Tuesday, November 27th. ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 27th. Raymond James set a $310.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a report on Wednesday, November 28th. Finally, Piper Jaffray Companies increased their price objective on UnitedHealth Group to $312.00 and gave the stock an “overweight” rating in a report on Wednesday, November 28th. Two equities research analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $297.80.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Compound Annual Growth Rate (CAGR)
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.